I don't know other sites about Triple Androgen Blockade Therapy.
Here's a link to the original Leibowitz abstract . . .
I chose TAB because I was not convinced (and I'm still not convinced) about the efficacy of the usual RP, RT, or Brachy treatments. I was offered high dose brachy + RT but the 8-year survival was only 85% and the bio failure rate at 8-years was nearly 25%. Leibowitz claims better data for TAB.
Please see the following link for a large comparative study of treatment outcomes, which states . . .
"Available data insufficiently characterize the relative benefits of various treatments for clinically localized prostate cancer, and all therapies cause some harms"
So if a doc tells you this or that treatment is best or the so-called "gold standard" you know they are taking rubbish. As Leibowitz is fond of saying . . . "Everyone is entitled to their (wrong) opinion."
I went to see Dr Steven Tucker in Singapore and we had a long talk about the options and I then decided on TAB. He worked with Leibowitz on the ASCO study.
Please note there are serious side effects of TAB, including loss of libido. That might be a serious concern to you since you are only 50 years old. It is claimed that no effect is permanent and can be treated, but please be warned it's not an easy route to take. Talk to you more about this if you're interested.
To add your signature, go to "Control Panel".
Hope this helps,
Diagnosed: June 2007. Aged 61. PSA 19.6. DRE negative.
Biopsy: June 2007; 2 cores of 18 positive.
MRI and Bone Scan: Negative.
Pathology: 5% of 1 core, "Small focus" in another core +ve.
Gleason 3 + 3 = 6.
Clinical: PCa considered confined to prostate. Stage T1c.
Treatment: After considering RP and HD Brachy, decided on Intermittent Triple Androgen Blockade Therapy for 1-year, using ZOLADEX, CASODEX 150 mg/day, AVODART 0.5 mg/day. Start PSA 19.2 (July 2007).
Completed Intermittent TAB on 23 July 2008, continue with AVODART alone and monitor PSA every 3-months. Changed to PROSCAR in Sept 2008.
Current Status: PSA = 0.22 (January 2009).
PSA nadir 0.01 (October 2008).